Messenger RNA Editing of the Human Serotonin 5-HT2C Receptor View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1999-08

AUTHORS

Lawrence W Fitzgerald, Geeta Iyer, Deborah S Conklin, Carol M Krause, Anne Marshall, John P Patterson, David P Tran, Gerald J Jonak, Paul R Hartig

ABSTRACT

RNA encoding the rat serotonin 5-HT2C receptor undergoes editing whereby one to four adenosines are converted to inosines. This conversion can change up to three codons out of a stretch of five in the second intracellular loop of the receptor. RNA editing of the rat 5-HT2C receptor that changes all three codons was shown previously to alter intracellular signaling by 5-HT without changing its receptor-binding affinity. We analyzed 5-HT2C receptor editing in human brain and hypothalamic RNA samples and confirmed that all four adenosine editing sites observed in rat were also present in human samples. Additionally, we identified a novel editing site in the middle edited codon that extends the repertoire of 5-HT2C receptors by six additional protein isoforms. We observed that editing reduces both the binding affinity and functional potency of agonists for recombinant human 5-HT2C receptor isoforms. This effect on binding affinity was proportional to the agonist's intrinsic activity, with full agonists most affected, and antagonists showing no effect. These data suggest that RNA editing may alter coupling energetics within the ternary complex, thereby altering agonist binding affinities, G protein coupling, and functional responses. RNA editing may thus provide a novel mechanism for regulating 5-HT synaptic signaling and plasticity. More... »

PAGES

82-90

Identifiers

URI

http://scigraph.springernature.com/pub.10.1016/s0893-133x(99)00004-4

DOI

http://dx.doi.org/10.1016/s0893-133x(99)00004-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1050840834

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10432493


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cloning, Molecular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polymerase Chain Reaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Isoforms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA Editing", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Messenger", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, Serotonin, 5-HT2C", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Serotonin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recombinant Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serotonin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serotonin Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serotonin Receptor Agonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transfection", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA", 
          "id": "http://www.grid.ac/institutes/grid.486911.3", 
          "name": [
            "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fitzgerald", 
        "givenName": "Lawrence W", 
        "id": "sg:person.01216612502.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216612502.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA", 
          "id": "http://www.grid.ac/institutes/grid.486911.3", 
          "name": [
            "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iyer", 
        "givenName": "Geeta", 
        "id": "sg:person.0634703650.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634703650.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA", 
          "id": "http://www.grid.ac/institutes/grid.486911.3", 
          "name": [
            "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Conklin", 
        "givenName": "Deborah S", 
        "id": "sg:person.01127632750.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127632750.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA", 
          "id": "http://www.grid.ac/institutes/grid.486911.3", 
          "name": [
            "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Krause", 
        "givenName": "Carol M", 
        "id": "sg:person.01175746150.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175746150.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA", 
          "id": "http://www.grid.ac/institutes/grid.486911.3", 
          "name": [
            "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marshall", 
        "givenName": "Anne", 
        "id": "sg:person.01151354220.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151354220.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA", 
          "id": "http://www.grid.ac/institutes/grid.486911.3", 
          "name": [
            "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Patterson", 
        "givenName": "John P", 
        "id": "sg:person.01312174550.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312174550.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA", 
          "id": "http://www.grid.ac/institutes/grid.486911.3", 
          "name": [
            "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tran", 
        "givenName": "David P", 
        "id": "sg:person.01360307750.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360307750.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA", 
          "id": "http://www.grid.ac/institutes/grid.486911.3", 
          "name": [
            "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jonak", 
        "givenName": "Gerald J", 
        "id": "sg:person.0622537576.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622537576.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA", 
          "id": "http://www.grid.ac/institutes/grid.486911.3", 
          "name": [
            "CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hartig", 
        "givenName": "Paul R", 
        "id": "sg:person.0771776602.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771776602.52"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/387303a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052290796", 
          "https://doi.org/10.1038/387303a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002130050585", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040696955", 
          "https://doi.org/10.1007/s002130050585"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1999-08", 
    "datePublishedReg": "1999-08-01", 
    "description": "RNA encoding the rat serotonin 5-HT2C receptor undergoes editing whereby one to four adenosines are converted to inosines. This conversion can change up to three codons out of a stretch of five in the second intracellular loop of the receptor. RNA editing of the rat 5-HT2C receptor that changes all three codons was shown previously to alter intracellular signaling by 5-HT without changing its receptor-binding affinity. We analyzed 5-HT2C receptor editing in human brain and hypothalamic RNA samples and confirmed that all four adenosine editing sites observed in rat were also present in human samples. Additionally, we identified a novel editing site in the middle edited codon that extends the repertoire of 5-HT2C receptors by six additional protein isoforms. We observed that editing reduces both the binding affinity and functional potency of agonists for recombinant human 5-HT2C receptor isoforms. This effect on binding affinity was proportional to the agonist's intrinsic activity, with full agonists most affected, and antagonists showing no effect. These data suggest that RNA editing may alter coupling energetics within the ternary complex, thereby altering agonist binding affinities, G protein coupling, and functional responses. RNA editing may thus provide a novel mechanism for regulating 5-HT synaptic signaling and plasticity.", 
    "genre": "article", 
    "id": "sg:pub.10.1016/s0893-133x(99)00004-4", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1099176", 
        "issn": [
          "0893-133X", 
          "1740-634X"
        ], 
        "name": "Neuropsychopharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "Suppl 1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "21"
      }
    ], 
    "keywords": [
      "agonist intrinsic activity", 
      "additional protein isoforms", 
      "G protein coupling", 
      "second intracellular loop", 
      "rat serotonin", 
      "receptor-binding affinity", 
      "full agonist", 
      "synaptic signaling", 
      "human serotonin", 
      "receptor isoforms", 
      "functional potency", 
      "agonists", 
      "protein coupling", 
      "receptor editing", 
      "receptors", 
      "intracellular loop", 
      "intrinsic activity", 
      "serotonin", 
      "human samples", 
      "rats", 
      "human brain", 
      "RNA editing", 
      "novel mechanism", 
      "novel editing sites", 
      "receptor undergoes", 
      "adenosine", 
      "messenger RNA editing", 
      "RNA samples", 
      "functional response", 
      "isoforms", 
      "antagonist", 
      "brain", 
      "intracellular", 
      "potency", 
      "editing sites", 
      "protein isoforms", 
      "signaling", 
      "affinity", 
      "effect", 
      "codon", 
      "ternary complex", 
      "response", 
      "RNA", 
      "editing", 
      "samples", 
      "inosine", 
      "plasticity", 
      "activity", 
      "sites", 
      "repertoire", 
      "mechanism", 
      "coupling energetics", 
      "data", 
      "stretch", 
      "complexes", 
      "middle", 
      "undergoes", 
      "loop", 
      "conversion", 
      "energetics", 
      "coupling"
    ], 
    "name": "Messenger RNA Editing of the Human Serotonin 5-HT2C Receptor", 
    "pagination": "82-90", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050840834"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1016/s0893-133x(99)00004-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10432493"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1016/s0893-133x(99)00004-4", 
      "https://app.dimensions.ai/details/publication/pub.1050840834"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_339.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1016/s0893-133x(99)00004-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1016/s0893-133x(99)00004-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1016/s0893-133x(99)00004-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1016/s0893-133x(99)00004-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1016/s0893-133x(99)00004-4'


 

This table displays all metadata directly associated to this object as RDF triples.

250 TRIPLES      21 PREDICATES      105 URIs      95 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1016/s0893-133x(99)00004-4 schema:about N00a97ad4141440d7b2477a0aa52da708
2 N0d196a737ac4453982e4081b25ddc132
3 N11db4d73321c4ac7879215f3b6f18f21
4 N1a1f857f5a484fa8b1d1ccce4d881c93
5 N23c02e9d2b6f4c10b422c20d4d7ab8c6
6 N2ecb57c0d1234e789a5ae517f97f91c6
7 N32f118cf63234f8199a063b5e33fe409
8 N398bc9a43bd14f53a9abce5f487f1400
9 N6a970819291a458fb1dac30641876d2f
10 N6c3e7f1752794e4abae886244a112779
11 N6f94334e6b6844e4b456cd64aca68494
12 N8c8c0b72ab4449ca82cd9630df673cd7
13 Nb8b1f691b5e6422fbe572d2b16e4de11
14 Nc892e03ac69e4081963a32e3ffe703b4
15 Nd11b6ecd302f444cbd113605f83b913f
16 Ndf8b087d2e1e4427bb3cef958ebf9aba
17 anzsrc-for:11
18 anzsrc-for:1109
19 schema:author Nc3f85e3463084daeba64d2d5098b28ef
20 schema:citation sg:pub.10.1007/s002130050585
21 sg:pub.10.1038/387303a0
22 schema:datePublished 1999-08
23 schema:datePublishedReg 1999-08-01
24 schema:description RNA encoding the rat serotonin 5-HT2C receptor undergoes editing whereby one to four adenosines are converted to inosines. This conversion can change up to three codons out of a stretch of five in the second intracellular loop of the receptor. RNA editing of the rat 5-HT2C receptor that changes all three codons was shown previously to alter intracellular signaling by 5-HT without changing its receptor-binding affinity. We analyzed 5-HT2C receptor editing in human brain and hypothalamic RNA samples and confirmed that all four adenosine editing sites observed in rat were also present in human samples. Additionally, we identified a novel editing site in the middle edited codon that extends the repertoire of 5-HT2C receptors by six additional protein isoforms. We observed that editing reduces both the binding affinity and functional potency of agonists for recombinant human 5-HT2C receptor isoforms. This effect on binding affinity was proportional to the agonist's intrinsic activity, with full agonists most affected, and antagonists showing no effect. These data suggest that RNA editing may alter coupling energetics within the ternary complex, thereby altering agonist binding affinities, G protein coupling, and functional responses. RNA editing may thus provide a novel mechanism for regulating 5-HT synaptic signaling and plasticity.
25 schema:genre article
26 schema:isAccessibleForFree true
27 schema:isPartOf N7cef4d9dfe444651930b357bf734bcaf
28 N8cc3ab04550948dab1ceb78f488feb21
29 sg:journal.1099176
30 schema:keywords G protein coupling
31 RNA
32 RNA editing
33 RNA samples
34 activity
35 additional protein isoforms
36 adenosine
37 affinity
38 agonist intrinsic activity
39 agonists
40 antagonist
41 brain
42 codon
43 complexes
44 conversion
45 coupling
46 coupling energetics
47 data
48 editing
49 editing sites
50 effect
51 energetics
52 full agonist
53 functional potency
54 functional response
55 human brain
56 human samples
57 human serotonin
58 inosine
59 intracellular
60 intracellular loop
61 intrinsic activity
62 isoforms
63 loop
64 mechanism
65 messenger RNA editing
66 middle
67 novel editing sites
68 novel mechanism
69 plasticity
70 potency
71 protein coupling
72 protein isoforms
73 rat serotonin
74 rats
75 receptor editing
76 receptor isoforms
77 receptor undergoes
78 receptor-binding affinity
79 receptors
80 repertoire
81 response
82 samples
83 second intracellular loop
84 serotonin
85 signaling
86 sites
87 stretch
88 synaptic signaling
89 ternary complex
90 undergoes
91 schema:name Messenger RNA Editing of the Human Serotonin 5-HT2C Receptor
92 schema:pagination 82-90
93 schema:productId N523b1e099f8a4711a680eb0761433fb0
94 Na01b2bcd02ce4d76b382a3ed7359016b
95 Nf100eb3653eb4649882ca75a3a4ccc11
96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050840834
97 https://doi.org/10.1016/s0893-133x(99)00004-4
98 schema:sdDatePublished 2022-10-01T06:31
99 schema:sdLicense https://scigraph.springernature.com/explorer/license/
100 schema:sdPublisher N06118641c50b40afa64e69cf0ac3af0c
101 schema:url https://doi.org/10.1016/s0893-133x(99)00004-4
102 sgo:license sg:explorer/license/
103 sgo:sdDataset articles
104 rdf:type schema:ScholarlyArticle
105 N00a97ad4141440d7b2477a0aa52da708 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Cloning, Molecular
107 rdf:type schema:DefinedTerm
108 N06118641c50b40afa64e69cf0ac3af0c schema:name Springer Nature - SN SciGraph project
109 rdf:type schema:Organization
110 N076317aa7920407bbc491cd96bf98c4e rdf:first sg:person.0622537576.05
111 rdf:rest Nbd6acef67be642f7ad52634614d6011d
112 N0d196a737ac4453982e4081b25ddc132 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Serotonin
114 rdf:type schema:DefinedTerm
115 N11db4d73321c4ac7879215f3b6f18f21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Serotonin Receptor Agonists
117 rdf:type schema:DefinedTerm
118 N1a1f857f5a484fa8b1d1ccce4d881c93 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Protein Isoforms
120 rdf:type schema:DefinedTerm
121 N23c02e9d2b6f4c10b422c20d4d7ab8c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Recombinant Proteins
123 rdf:type schema:DefinedTerm
124 N2ecb57c0d1234e789a5ae517f97f91c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Receptor, Serotonin, 5-HT2C
126 rdf:type schema:DefinedTerm
127 N32f118cf63234f8199a063b5e33fe409 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Polymerase Chain Reaction
129 rdf:type schema:DefinedTerm
130 N398bc9a43bd14f53a9abce5f487f1400 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Rats
132 rdf:type schema:DefinedTerm
133 N410aa437be704575b873927903a4fccd rdf:first sg:person.0634703650.16
134 rdf:rest Nd295a9e9035a40ef985dc781dc419674
135 N46dc479490aa4c07a19baaf91a3df4a2 rdf:first sg:person.01360307750.53
136 rdf:rest N076317aa7920407bbc491cd96bf98c4e
137 N523b1e099f8a4711a680eb0761433fb0 schema:name pubmed_id
138 schema:value 10432493
139 rdf:type schema:PropertyValue
140 N6a970819291a458fb1dac30641876d2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Animals
142 rdf:type schema:DefinedTerm
143 N6c3e7f1752794e4abae886244a112779 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Receptors, Serotonin
145 rdf:type schema:DefinedTerm
146 N6df7b8fb8a2e450ba2a96e155f3a9e15 rdf:first sg:person.01175746150.27
147 rdf:rest Ne8bbe8f6dbc2426bba9e08de000ecd00
148 N6f94334e6b6844e4b456cd64aca68494 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Serotonin Antagonists
150 rdf:type schema:DefinedTerm
151 N7cef4d9dfe444651930b357bf734bcaf schema:volumeNumber 21
152 rdf:type schema:PublicationVolume
153 N8c8c0b72ab4449ca82cd9630df673cd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Cell Line
155 rdf:type schema:DefinedTerm
156 N8cc3ab04550948dab1ceb78f488feb21 schema:issueNumber Suppl 1
157 rdf:type schema:PublicationIssue
158 Na01b2bcd02ce4d76b382a3ed7359016b schema:name doi
159 schema:value 10.1016/s0893-133x(99)00004-4
160 rdf:type schema:PropertyValue
161 Nb8b1f691b5e6422fbe572d2b16e4de11 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name RNA Editing
163 rdf:type schema:DefinedTerm
164 Nbd6acef67be642f7ad52634614d6011d rdf:first sg:person.0771776602.52
165 rdf:rest rdf:nil
166 Nc3f85e3463084daeba64d2d5098b28ef rdf:first sg:person.01216612502.75
167 rdf:rest N410aa437be704575b873927903a4fccd
168 Nc892e03ac69e4081963a32e3ffe703b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name RNA, Messenger
170 rdf:type schema:DefinedTerm
171 Nd11b6ecd302f444cbd113605f83b913f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Transfection
173 rdf:type schema:DefinedTerm
174 Nd14d3a45c8994bbbbe64832f4e2cdd9d rdf:first sg:person.01312174550.13
175 rdf:rest N46dc479490aa4c07a19baaf91a3df4a2
176 Nd295a9e9035a40ef985dc781dc419674 rdf:first sg:person.01127632750.14
177 rdf:rest N6df7b8fb8a2e450ba2a96e155f3a9e15
178 Ndf8b087d2e1e4427bb3cef958ebf9aba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Humans
180 rdf:type schema:DefinedTerm
181 Ne8bbe8f6dbc2426bba9e08de000ecd00 rdf:first sg:person.01151354220.80
182 rdf:rest Nd14d3a45c8994bbbbe64832f4e2cdd9d
183 Nf100eb3653eb4649882ca75a3a4ccc11 schema:name dimensions_id
184 schema:value pub.1050840834
185 rdf:type schema:PropertyValue
186 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
187 schema:name Medical and Health Sciences
188 rdf:type schema:DefinedTerm
189 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
190 schema:name Neurosciences
191 rdf:type schema:DefinedTerm
192 sg:journal.1099176 schema:issn 0893-133X
193 1740-634X
194 schema:name Neuropsychopharmacology
195 schema:publisher Springer Nature
196 rdf:type schema:Periodical
197 sg:person.01127632750.14 schema:affiliation grid-institutes:grid.486911.3
198 schema:familyName Conklin
199 schema:givenName Deborah S
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127632750.14
201 rdf:type schema:Person
202 sg:person.01151354220.80 schema:affiliation grid-institutes:grid.486911.3
203 schema:familyName Marshall
204 schema:givenName Anne
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151354220.80
206 rdf:type schema:Person
207 sg:person.01175746150.27 schema:affiliation grid-institutes:grid.486911.3
208 schema:familyName Krause
209 schema:givenName Carol M
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175746150.27
211 rdf:type schema:Person
212 sg:person.01216612502.75 schema:affiliation grid-institutes:grid.486911.3
213 schema:familyName Fitzgerald
214 schema:givenName Lawrence W
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216612502.75
216 rdf:type schema:Person
217 sg:person.01312174550.13 schema:affiliation grid-institutes:grid.486911.3
218 schema:familyName Patterson
219 schema:givenName John P
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312174550.13
221 rdf:type schema:Person
222 sg:person.01360307750.53 schema:affiliation grid-institutes:grid.486911.3
223 schema:familyName Tran
224 schema:givenName David P
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360307750.53
226 rdf:type schema:Person
227 sg:person.0622537576.05 schema:affiliation grid-institutes:grid.486911.3
228 schema:familyName Jonak
229 schema:givenName Gerald J
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622537576.05
231 rdf:type schema:Person
232 sg:person.0634703650.16 schema:affiliation grid-institutes:grid.486911.3
233 schema:familyName Iyer
234 schema:givenName Geeta
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634703650.16
236 rdf:type schema:Person
237 sg:person.0771776602.52 schema:affiliation grid-institutes:grid.486911.3
238 schema:familyName Hartig
239 schema:givenName Paul R
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771776602.52
241 rdf:type schema:Person
242 sg:pub.10.1007/s002130050585 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040696955
243 https://doi.org/10.1007/s002130050585
244 rdf:type schema:CreativeWork
245 sg:pub.10.1038/387303a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052290796
246 https://doi.org/10.1038/387303a0
247 rdf:type schema:CreativeWork
248 grid-institutes:grid.486911.3 schema:alternateName CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA
249 schema:name CNS Diseases Research, The DuPont Pharmaceuticals Research Laboratories, Experimental Station, Wilmington, Delaware, USA
250 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...